Trialogics
Trialogics is a privately held clinical trial software and managed device provider that sells integrated eConsent, IRT/IWRS, ePRO/eCOA, and Remote Device Management modules to pharmaceutical sponsors and CROs running global trials, with bundled Samsung hardware provisioning.
- Company typePrivate
- Founded2015
- HeadquartersWilmington, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Trialogics does
Trialogics is a clinical trial technology and logistics provider founded in 2015 by CEO Christopher Gropp and headquartered in Wilmington, Delaware. The company sells a cloud-based eClinical software platform composed of four integrated modules — eConsent (with DocuSign integration), IRT/IWRS for randomization and clinical supply management, ePRO/eCOA for electronic patient-reported outcomes, and Remote Device Management — to pharmaceutical and biotech sponsors and to Contract Research Organizations (CROs) running decentralized and hybrid trials. Trialogics differentiates through bundled hardware provisioning: it procures Samsung devices (tablets, laptops, wearables, medical sensors), secures them with Samsung Knox, manages them with IBM MaaS360, and ships them globally with mobile data plans included, claiming compliance rates above 95% among sites and subjects using these devices.
The platform is hosted on Microsoft Azure, with data held in an ISO 27001-certified data center and operations aligned to GDPR, EU-U.S./UK/Swiss Data Privacy Frameworks, CCPA, and WCAG 2.2 AA accessibility standards. Revenue is generated through multi-year enterprise subscriptions for the four software modules, hardware/device provisioning fees, and professional services including on-site and remote training plus 24/7/365 support. In October 2025 Trialogics layered on Tria, an NLP-based AI assistant that delivers role-based access to trial data through a conversational interface.
The company is privately held and founder-controlled, with no disclosed institutional funding. It maintains offices in Wilmington (Paris), London (opened August 2023 post-Brexit), and Sydney (opened 2024), and serves North America, Europe, and the Asia-Pacific region through a direct enterprise field-sales motion targeting sponsors and CROs. Strategic partnerships include Samsung (since 2018), IBM, Microsoft Azure, DocuSign, Lotus Clinical Research (CNS-focused CRO, June 2023), and Strados Labs (October 2024).
Trialogics firmographics
Firmographics- Name
- Trialogics
- Legal name
- Trialogics LLC
- Website
- https://trialogics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Trialogics is a privately held clinical trial software and managed device provider that sells integrated eConsent, IRT/IWRS, ePRO/eCOA, and Remote Device Management modules to pharmaceutical sponsors and CROs running global trials, with bundled Samsung hardware provisioning.
- Ownership category
- akta.pro rank
Trialogics industry classification
Industry- Product category
- Clinical Trial Software
- NAICS
- Computer Systems Design Services (541512), Other Computer Related Services (541519)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS) (HLACAOAC)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), eConsent & Digital Identity for Trials (HLACAOAE), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where Trialogics is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Trialogics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Clinical Trial Software Subscriptions: Trialogics provides eConsent, IRT/IWRS, eCOA/ePRO, and Remote Device Management services as individual modules or as a fully integrated solution. Services are provided to clinical trial sponsors and CROs, typically under multi-year contractual arrangements for ongoing trials that span phases.
- Hardware Sales / Device Provisioning: Trialogics procures and provisions Samsung devices (tablets, laptops, Chromebooks, smartwatches, mobile phones) along with mobile data plans, deploying them to clinical trial sites and subjects. Devices are configured with Samsung Knox security and managed via IBM MaaS. Revenue includes hardware provisioning costs as part of the managed service offering.
- Professional Services and Training: Customized training is available in various formats to ensure clinical trial staff are prepared. On-site and remote training services support system adoption and compliance. Support services available 24/7/365.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Trialogics product offering
Product offeringCore offering
Trialogics provides cloud-based clinical trial software solutions — eConsent, IRT/IWRS, ePRO/eCOA, and Remote Device Management — sold as individual modules or as a fully integrated platform. The company also provisions and manages secured Samsung devices (tablets, laptops, wearables) with global mobile data plans for decentralized trial sites and subjects. The platform is built on Microsoft Azure with Samsung Knox security and IBM MaaS device management, and includes an AI-powered assistant (Tria) for role-based clinical trial query handling.
Product overview
Trialogics offers a cloud-based clinical trial software platform composed of four integrated core products: eConsent (electronic informed consent), IRT/IWRS (clinical supply management and treatment assignment), ePRO/eCOA (subject diaries and patient-reported outcomes), and Remote Device Management (device deployment and security for sites and subjects). Services can be used individually or as a fully integrated solution, unified by cloud-based technology and supported by a global mobile device deployment network with Samsung hardware, Samsung Knox, and IBM MaaS360 integrations.
Differentiator
Problem solved
Functional benefit
Products and services
- eConsent Electronic Informed Consent solution that enables clinical trial participants to review, sign, and manage informed consent documents digitally, replacing paper-based consent processes. Integrated with DocuSign for signature workflows and built for clinical trial sponsors and CROs.
- IRT/IWRS Interactive Response Technology / Interactive Web Response System providing clinical supply management, subject management, and treatment assignment capabilities, including randomization for clinical trial sponsors and CROs.
- ePRO/eCOA Electronic Patient-Reported Outcomes / Electronic Clinical Outcome Assessment solution enabling subject diaries, questionnaires, and patient-reported data collection for clinical trial sponsors and CROs.
- Remote Device Management Remote device management service for clinical trial sites and subjects, covering deployment, management, and security of laptops, tablets, wearables, and remote medical devices with global mobile connectivity. Uses Samsung Knox security and IBM MaaS MDM.
- Tria AI Assistant AI-powered assistant for clinical trial operations that uses Natural Language Processing to provide role-based text responses to clinical trial queries, streamlining operations, improving data access, and reducing site burden through a secure conversational interface for clinical trial sponsors, CROs, and site staff.
Quantifiable outcome
- Compliance rates exceeding 95% for sites and subjects using Samsung devices
- +2 more outcomes
Companies that use Trialogics
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Trialogics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature6 records
Trialogics partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Strados LabsminorStrados Labs, a medical technology company, announced a new partnership with Trialogics to enhance global distribution to clinical trials. Strados Labs' sensor technology for clinical trials is distributed through Trialogics' platform and device management infrastructure, expanding reach to Trialogics' global client base.
- Lotus Clinical ResearchcoreLotus Clinical Research, a CNS-focused CRO headquartered in California, entered a strategic partnership with Trialogics in June 2023 to strengthen their existing relationship and expand Lotus's use of Trialogics' clinical trial software offerings. The partnership improved data collection methods, streamlined trial processes, and enhanced data quality. The collaboration reduced interview bias in CNS studies and optimized randomization and drug supply management (IRT) processes.
- SamsungcoreSamsung is a core technology partner providing devices (tablets, laptops, Chromebooks, smartwatches, mobile phones, remote medical devices) used in Trialogics' Remote Device Management solution. Devices are secured using Samsung Knox and provided to clinical trial sites and subjects with mobile data plans. Trialogics has partnered with Samsung since 2018 and uses Samsung devices in nearly all their trials.
- IBMcoreIBM is a technology partner providing IBM MaaS (Mobile Device Management as a Service) used by Trialogics to manage and secure devices deployed in clinical trials. IBM MaaS enables Trialogics to configure, monitor, update, and remotely lock/wipe devices deployed across global trial sites.
- Microsoft AzurecoreMicrosoft Azure provides the cloud infrastructure underpinning Trialogics' software platform. Azure hosts the clinical trial software applications and Trialogics database, enabling secure, scalable delivery of eConsent, IRT, eCOA, and Remote Device Management services globally.
- DocuSigncoreDocuSign is integrated with Trialogics' eConsent solution to provide electronic signature capabilities for informed consent documents. This enables seamless digital consent capture that meets regulatory requirements for clinical trial enrollment.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Trialogics competitors and assessment
Company assessmentDirect peers
- Medable: Medable offers a decentralized clinical trial platform with eConsent, eCOA, and remote device integration. It is a direct competitor in the hybrid/decentralized trial segment where Trialogics positions itself, particularly for sponsor-direct contracts.
- Veeva Systems: Veeva's Vault eClinical suite includes eConsent, IRT, and EDC modules directly overlapping with Trialogics' core offerings. Veeva is the closest large-cap competitor serving pharma sponsors and CROs with cloud-based clinical trial software.
- Castor EDC: Castor offers a cloud-based clinical trial platform spanning EDC, eConsent, ePRO, and decentralized trial features — directly competing with Trialogics' modular suite, particularly for academic and mid-sized sponsor customers.
- YPrime: YPrime provides eClinical software including IRT, eCOA, and eConsent with strong device-management capabilities — closely comparable to Trialogics' integrated offering for mid-sized pharma and CRO customers.
- Signant Health: Signant Health specializes in eCOA/ePRO, eConsent, and patient engagement for clinical trials — overlapping closely with Trialogics' ePRO/eCOA and eConsent modules and serving the same pharma and CRO buyer base.
- Suvoda: Suvoda specializes in IRT/IWRS for clinical trials with a strong focus on randomization and trial supply management — directly overlapping with Trialogics' IRT/IWRS module and serving similar oncology and rare disease trial sponsors.
- Medidata Solutions (Dassault Systèmes): Medidata's Rave platform covers EDC, eCOA, randomization, and eConsent — the same core modules Trialogics offers. It is the most established integrated eClinical suite for global pharma trials and a direct competitor for sponsor master agreements.
- THREAD: THREAD provides a unified decentralized and hybrid trial platform including eCOA, eConsent, telehealth, and device integration — directly comparable to Trialogics' integrated suite for sponsor and CRO customers running hybrid studies.
Broad incumbents
- IQVIA (formerly QuintilesIMS):
- Oracle Health Sciences (formerly Phase Forward): Oracle Health Sciences provides a broad eClinical and safety platform including EDC, IRT, and clinical trial analytics. As a broad incumbent in life sciences software, Oracle competes with Trialogics at large pharma accounts but across a much wider portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Trialogics social profiles
Digital presenceTrialogics compliance and trust
Trust signalCompliance5 records
Trialogics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trialogics leadership team
Management profileNumber of profiles
Profiles3 records
Trialogics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trialogics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trialogics
What does Trialogics do?
Trialogics provides cloud-based clinical trial software solutions — eConsent, IRT/IWRS, ePRO/eCOA, and Remote Device Management — sold as individual modules or as a fully integrated platform. The company also provisions and manages secured Samsung devices (tablets, laptops, wearables) with global mobile data plans for decentralized trial sites and subjects. The platform is built on Microsoft Azure with Samsung Knox security and IBM MaaS device management, and includes an AI-powered assistant (Tria) for role-based clinical trial query handling.
Is Trialogics a public or private company?
Trialogics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Trialogics founded?
Trialogics was founded in 2015. It employs 11 to 50 people.
Where is Trialogics based?
Trialogics is headquartered in Wilmington, United States, in the North America region.
How does Trialogics make money?
Three revenue lines are on record. Clinical Trial Software Subscriptions are the primary driver. The others are hardware Sales / Device Provisioning and professional Services and Training.
Who are Trialogics's main competitors?
Direct peers on record are Medable, Veeva Systems, Castor EDC, YPrime, Signant Health, Suvoda, Medidata Solutions (Dassault Systèmes) and THREAD. Broad incumbents are IQVIA (formerly QuintilesIMS) and Oracle Health Sciences (formerly Phase Forward).
Does Trialogics have an API?
No public API is recorded for Trialogics.
What industry is Trialogics in?
Trialogics's product category is Clinical Trial Software. Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 541512 and its SIC code is 7372.